Nirsevimab - healthylife7.com

Browsing: Nirsevimab

Nirsevimab Immunization Reduces IPD Hospitalization Risk in Infants

By healthylife7August 11, 20260

Real-world data show invasive pneumococcal disease (IPD) risk is significantly reduced with nirsevimab immunization among infants younger than 12 months of age, according to study results published in The Lancet Infectious Diseases

What's Hot

Russia releases former US Marine reported in poor health

Kloeckner Metals earns two major wellness recognitions, highlighting its commitment to employee well

Steroid Curbs Chronic Lung Inflammation Without Weakening Immune Defenses

Browsing: Nirsevimab

Nirsevimab Immunization Reduces IPD Hospitalization Risk in Infants

Russia releases former US Marine reported in poor health

Kloeckner Metals earns two major wellness recognitions, highlighting its commitment to employee well

Steroid Curbs Chronic Lung Inflammation Without Weakening Immune Defenses

How to start a fitness routine with just 10 minutes per day

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

Fitness

Russia releases former US Marine reported in poor health

Kloeckner Metals earns two major wellness recognitions, highlighting its commitment to employee well

Steroid Curbs Chronic Lung Inflammation Without Weakening Immune Defenses

Health

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

Subscribe to Updates

What's Hot

Browsing: Nirsevimab